Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

Nigeria flag Nigeria · Delayed Price · Currency is NGN
10.60
-0.95 (-8.23%)
At close: Mar 2, 2026
249.83%
Market Cap 45.29B
Revenue (ttm) 7.37B
Net Income (ttm) 982.11M
Shares Out 4.27B
EPS (ttm) 0.23
PE Ratio 46.13
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,651,422
Average Volume 5,239,457
Open 10.60
Previous Close 11.55
Day's Range 10.60 - 10.60
52-Week Range 2.42 - 16.15
Beta 0.75
RSI 43.75
Earnings Date Jan 28, 2026

About NGX:NEIMETH

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health products in Nigeria and Ghana. It provides health care, ethical, and veterinary related products; and poultry and animal range of anthelmintic products, as well as production enhancing medicaments. The company was formerly known as Pfizer Inc. and changed its name to Neimeth International Pharmaceuticals Plc. In 1997. Neimeth International Pharmaceuticals Plc was incorporated in 1957 and is based in Lagos, Nigeria. [Read more]

Industry Pharmaceutical Preparations
Founded 1957
Employees 175
Stock Exchange Nigerian Stock Exchange
Ticker Symbol NEIMETH
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.